Pharmacological Analysis of Calcium Responses Mediated by the Human A3 Adenosine Receptor in Monocyte-Derived Dendritic Cells and Recombinant Cells
Molecular Pharmacology, ISSN: 0026-895X, Vol: 63, Issue: 2, Page: 342-350
2003
- 60Citations
- 22Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations60
- Citation Indexes60
- 60
- CrossRef52
- Captures22
- Readers22
- 22
Article Description
Extensive characterization of adenosine receptors expressed by human monocyte-derived dendritic cells (MDDCs) was performed with quantitative polymerase chain reaction, radioligand binding, and calcium signaling. Transcript for the A3 adenosine receptor was elevated more than 100-fold in immature MDDCs compared with monocyte precursors. A3 receptor transcript was substantially diminished, and A2A receptor transcript increased, by lipopolysaccharide maturation of MDDCs. Saturation binding of N 6 -(3-[ 125 I]iodo-4-aminobenzyl)-adenosine-5′- N -methyluronamide ([ 125 I]AB-MECA) to membranes from immature MDDCs yielded B max of 298 fmol/mg of protein and K D of 0.7 nM. Competition against [ 125 I]AB-MECA binding confirmed the site to be the A3 receptor. Adenosine elicited pertussis toxin-sensitive calcium responses with EC 50 values ranging as low as 2 nM. The order of potency for related agonists was N 6 -(3-iodobenzyl)-adenosine-5′- N -methylcarboxamide (IB-MECA) ≥ I-AB-MECA > 2Cl-IB-MECA ≥ adenosine > 2-[ p -(2-carboxyethyl)phenylethylamino]-5′- N -ethylcarboxyamidoadenosine (CGS21680). The order of efficacy was adenosine ≥ CGS21680 > IB-MECA ≥ I-AB-MECA > 2Cl-IB-MECA. Calcium responses to 2Cl-IB-MECA and CGS21680, and the lower range of adenosine concentrations, were completely blocked by 10 nM N -(2-methoxyphenyl)- N -[2-(3-pyridyl)quinazolin-4-yl]urea (VUF5574) but not by 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3- e ]-1,2,4-triazolo[1,5- c ]pyrimidine (SCH58261) or 8-cyclopentyl-1,3-dipropylxanthine. Pretreatment with 100 nM 2Cl-IB-MECA eliminated responses to CGS21680 but not to monocyte inhibitory protein-1α. For comparison, dose-response functions were obtained from double-recombinant human embryonic kidney 293 cells expressing the human A3 receptor and a chimeric Gαq-i3 protein, which was required to establish A3-mediated calcium signaling. The pharmacological profile of calcium signaling elicited by adenosine-related agonists in the double-recombinant cells was essentially identical to that obtained from immature MDDCs. Our results provide an extensive analysis of A3-mediated calcium signaling and unequivocally identify immature MDDCs as native expressers of the human A3 receptor.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0026895X24057286; http://dx.doi.org/10.1124/mol.63.2.342; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0037308772&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/12527805; https://linkinghub.elsevier.com/retrieve/pii/S0026895X24057286; https://dx.doi.org/10.1124/mol.63.2.342; https://molpharm.aspetjournals.org/content/63/2/342
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know